Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study
- PMID: 27353609
- PMCID: PMC4937277
- DOI: 10.1161/JAHA.116.003371
Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study
Abstract
Background: Despite evidence for higher risk of coronary artery disease among HIV+ individuals, the underlying mechanisms are not well understood. We investigated associations of inflammatory markers with subclinical coronary artery disease in 923 participants of the Multicenter AIDS Cohort Study (575 HIV+ and 348 HIV- men) who underwent noncontrast computed tomography scans for coronary artery calcification, the majority (n=692) also undergoing coronary computed tomography angiography.
Methods and results: Outcomes included presence and extent of coronary artery calcification, plus computed tomography angiography analysis of presence, composition, and extent of coronary plaques and severity of coronary stenosis. HIV+ men had significantly higher levels of interleukin-6 (IL-6), intercellular adhesion molecule-1, C-reactive protein, and soluble-tumor necrosis factor-α receptor (sTNFαR) I and II (all P<0.01) and a higher prevalence of noncalcified plaque (63% versus 54%, P=0.02) on computed tomography angiography. Among HIV+ men, for every SD increase in log-interleukin-6 and log intercellular adhesion molecule-1, there was a 30% and 60% increase, respectively, in the prevalence of coronary stenosis ≥50% (all P<0.05). Similarly, sTNFαR I and II in HIV+ participants were associated with an increase in prevalence of coronary stenosis ≥70% (P<0.05). Higher levels of interleukin-6, sTNFαR I, and sTNFαR II were also associated with greater coronary artery calcification score in HIV+ men (P<0.01).
Conclusions: Higher inflammatory marker levels are associated with greater prevalence of coronary stenosis in HIV+ men. Our findings underscore the need for further study to elucidate the relationships of inflammatory pathways with coronary artery disease in HIV+ individuals.
Keywords: HIV; HIV infection; atherosclerosis; cardiac biomarkers; cardiac computed tomography; coronary artery calcium; coronary artery disease; coronary computed tomography scan; epidemiology; inflammation.
© 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.
Figures

Similar articles
-
Extra-coronary calcification (aortic valve calcification, mitral annular calcification, aortic valve ring calcification and thoracic aortic calcification) in HIV seropositive and seronegative men: Multicenter AIDS Cohort Study.J Cardiovasc Comput Tomogr. 2016 May-Jun;10(3):229-236. doi: 10.1016/j.jcct.2016.02.002. Epub 2016 Feb 27. J Cardiovasc Comput Tomogr. 2016. PMID: 26949197 Free PMC article.
-
Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.J Infect Dis. 2015 Apr 15;211(8):1219-28. doi: 10.1093/infdis/jiu594. Epub 2014 Oct 30. J Infect Dis. 2015. PMID: 25362192 Free PMC article.
-
hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial.JACC Cardiovasc Imaging. 2015 Nov;8(11):1272-1281. doi: 10.1016/j.jcmg.2015.06.016. Epub 2015 Oct 14. JACC Cardiovasc Imaging. 2015. PMID: 26476506 Free PMC article. Clinical Trial.
-
Genetics paired with CT angiography in the setting of atherosclerosis.Clin Imaging. 2016 Sep-Oct;40(5):917-25. doi: 10.1016/j.clinimag.2016.04.005. Epub 2016 Apr 26. Clin Imaging. 2016. PMID: 27183141 Review.
-
Application of Non-invasive Imaging in Inflammatory Disease Conditions to Evaluate Subclinical Coronary Artery Disease.Curr Rheumatol Rep. 2019 Dec 12;22(1):1. doi: 10.1007/s11926-019-0875-0. Curr Rheumatol Rep. 2019. PMID: 31832865 Review.
Cited by
-
Cardiovascular risk factors and illicit drug use may have a more profound effect on coronary atherosclerosis progression in people living with HIV.Eur Radiol. 2021 May;31(5):2756-2767. doi: 10.1007/s00330-021-07755-7. Epub 2021 Mar 3. Eur Radiol. 2021. PMID: 33660033 Free PMC article.
-
The Opioid Epidemic: Impact on Inflammation and Cardiovascular Disease Risk in HIV.Curr HIV/AIDS Rep. 2019 Oct;16(5):381-388. doi: 10.1007/s11904-019-00463-4. Curr HIV/AIDS Rep. 2019. PMID: 31473903 Free PMC article. Review.
-
Cumulative Human Immunodeficiency Viremia, Antiretroviral Therapy, and Incident Myocardial Infarction.Epidemiology. 2019 Jan;30(1):69-74. doi: 10.1097/EDE.0000000000000930. Epidemiology. 2019. PMID: 30273188 Free PMC article.
-
HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women.JACC Basic Transl Sci. 2022 Jan 19;7(4):410-421. doi: 10.1016/j.jacbts.2021.10.017. eCollection 2022 Apr. JACC Basic Transl Sci. 2022. PMID: 35540101 Free PMC article. Review.
-
The impact of long-term moderate and heavy alcohol consumption on incident atherosclerosis among persons living with HIV.Drug Alcohol Depend. 2017 Dec 1;181:235-241. doi: 10.1016/j.drugalcdep.2017.09.034. Epub 2017 Oct 28. Drug Alcohol Depend. 2017. PMID: 29121596 Free PMC article.
References
-
- WHO, UNICEF, UNAIDS . Global HIV/AIDS response: epidemic update and health sector progress towards universal access. Progress report. 2011.
-
- Ho JE, Hsue PY. Cardiovascular manifestations of HIV infection. Heart. 2009;95:1193–1202. - PubMed
-
- Sudano I, Spieker LE, Noll G, Corti R, Weber R, Luscher TF. Cardiovascular disease in HIV infection. Am Heart J. 2006;151:1147–1155. - PubMed
-
- Thienemann F, Sliwa K, Rockstroh JK. HIV and the heart: the impact of antiretroviral therapy: a global perspective. Eur Heart J. 2013;34:3538–3546. - PubMed
-
- Neumann T, Esser S, Potthoff A, Pankuweit S, Neumann A, Breuckmann F, Neuhaus K, Kondratieva J, Buck T, Muller‐Tasch T, Wachter R, Prettin C, Gelbrich G, Herzog W, Pieske B, Rauchhaus M, Loffler M, Maisch B, Mugge A, Wasem J, Gerken G, Brockmeyer NH, Erbel R. Prevalence and natural history of heart failure in outpatient HIV‐infected subjects: rationale and design of the HIV‐HEART study. Eur J Med Res. 2007;12:243–248. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials